ERIS Lifesciences consolidated net profit rises 1.08% in the December 2022 quarter





Business Standard







Sales rise 27.36% to Rs 417.84 crore

Net profit of ERIS Lifesciences rose 1.08% to Rs 101.86 crore in the quarter ended December 2022 as against Rs 100.77 crore during the previous quarter ended December 2021. Sales rose 27.36% to Rs 417.84 crore in the quarter ended December 2022 as against Rs 328.07 crore during the previous quarter ended December 2021.

ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales417.84328.07 27 OPM %32.8437.10 PBDT136.44125.86 8 PBT106.54108.98 -2 NP101.86100.77 1

Powered by Capital Market – Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)



Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!



First Published: Wed, January 18 2023. 07:36 IST


RECOMMENDED FOR YOU





RECOMMENDED FOR YOU










Leave a Comment